期刊文献+

甲状腺激素替代治疗对老年甲状腺功能减退患者血脂及心功能的影响 被引量:1

Influnce of thyroid hormone replacement therapy on lipid and heart function of elderly patients with hypothyroidism
下载PDF
导出
摘要 目的分析甲状腺激素替代治疗对老年甲状腺功能减退患者血脂及心功能的影响。方法取本院内分泌科于2008年9月~2012年9月间门诊及住院收治的老年甲状腺功能减退患者176例作为研究对象,所有患者均给予甲状腺激素替代治疗,比较患者接受治疗前后的甲状腺功能指标、血脂相关指标、心功能指标水平。结果所有患者接受治疗后的平均TSH值明显低于治疗前水平,FT3及FT4平均值均明显高于治疗前(P<0.05);所有患者接受治疗后的血脂指标平均值均明显低于治疗前(P<0.05);接受治疗后患者的心功能明显改善,治疗后的左室射血分数及左室舒张功能值均明显高于治疗前(P<0.05)。结论使用甲状腺激素替代治疗老年甲状腺功能减退,在有效增强甲状腺功能的同时,可以明显改善患者的血脂水平及心功能。 Objective To analyze the effect of decreased blood thyroid hormone replacement therapy and cardiac function in elderly patients with thyroid function. Methods All of 176 cases of elderly patients with hypothyroidism from September 2008 to September 2012 were treated with thyroid hormone replacement therapy, compared with patients before and after treatment, thyroid function index, serum lipids, heart function index difference. Results All the patients after treatment the average vlue of TSH was obviously lower than that before treatment, FT3 and FT4 were significantly higher than average value before treatment (P 〈 0.05). After treatment, blood lipid index average values were significantly lower than those before treatment (P 〈 0.05), heart function of patients after treatment significantly improved after treatment, left ventricular the ejection fraction and left ventricular diastolic function were signifieantly higher than those before treatment (P 〈 0.05). Conclusion The use of thyroid hormone replacement therapy in elderly hypothyroidism, effectively enhance the thyroid function at the same time, can significantly improve the blood lipid level and heart function in patients.
出处 《中国现代医生》 2013年第15期56-57,60,共3页 China Modern Doctor
基金 国家自然科学基金(81072182)
关键词 甲状腺激素 甲状腺功能减退 血脂 心功能 Thyroid hormone Hypothyroidism Blood lipid Cardiac function
  • 相关文献

参考文献11

二级参考文献44

  • 1汪艳芳,马书平,苏永,赵志刚.老年与中青年甲亢的临床特点对比及误诊分析[J].中国误诊学杂志,2004,4(3):412-413. 被引量:14
  • 2徐华,高燕燕,关建民,黄志宏,姜冬青,赵家军.原发性甲减患者左旋甲状腺素治疗后血脂、心肌酶谱及体成分的变化[J].中华内分泌代谢杂志,2005,21(2):110-113. 被引量:46
  • 3Paros F,Awa Ⅱ,Rubicspat J,et al.Long term thyroid replacement therapy and levels of lipoprotein(α)and other lioproteins[J].J Clin Endocrinol Mctak,1995,80(2):562.
  • 4Cros G,Sykes M,Arelano R,et al.Clearance and receptor catabplism of LDL are reduced in hypothyroid rats[J].Atherosclerosis,1987,66:269-275.
  • 5Vierhapper H,Narcli A,crosser P,et al.Low-density lipoprotein cholesterol in subclinical hypothyroidism[J].Thyroid,2000,10(11):981-984.
  • 6Sasakj S,Kawai K,Honjo Y,et al.Thyroid homoncs and lipid metabolism[J].Nippon Rinsho,2006,64(12):2323-2329.
  • 7史轶繁.协和内分泌和代谢病学.北京科学出版社1999:1043-1051.
  • 8CanarisGJ, Manowitz NR, Mayor G, et al. The colorado thyroid disease prevalence study. Arch lnterm Med 2000; 160:526 - 534.
  • 9Bhansali A,Sreenivasulu P,Khandelwal N,et al.Reversibility of thyrotroph hyperplasia after L-thyroxine replacement therapy in patients with juvenile primary hypothyroidism.J Pediatr Endocrinol Metah,2004,17:655-661.
  • 10Hurley DM,Ho KK.Pituitary disease in adults.Endocrinolgy,2004,180:419-425.

共引文献83

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部